SciELO - Scientific Electronic Library Online

vol.64 número1Estrategias no farmacológicas para el manejo de los síntomas vasomotores en la menopausiaMuerte fetal intrauterina de uno de los gemelos índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO


Revista Peruana de Ginecología y Obstetricia

versión On-line ISSN 2304-5132


PILNIK, Susana; GELIN, Marina; NARDO, Bárbara De  y  BELARDO, María Alejandra. Treatment of vasomotor symptoms in patients with breast cancer, a narrative review. Rev. peru. ginecol. obstet. [online]. 2018, vol.64, n.1, pp.69-76. ISSN 2304-5132.

Women with a history of breast cancer tend to have more severe and frequent vasomotor symptoms than the general population. Numerous studies have shown that vasomotor symptoms (VMS) are the most frequent adverse event of adjuvant therapy, and that up to 20% of breast cancer patients consider discontinuing treatment because of these symptoms, despite their benefit in the reduction of recurrence. While hormone replacement therapy (HRT) is regularly used in healthy women to treat VMS, it is contraindicated in patients with history of breast cancer. There are few clinical data on non-pharmacological interventions, and the role of alternative and complementary therapies remains controversial. The review of the literature reveals that these pharmacological agents, serotonin-norepinephrine reuptake inhibitors (SSRIs), selective serotonin reuptake inhibitors (IRSs), antihypertensives and anticonvulsants, decrease the intensity and frequency of VMS, demonstrating a clinically significant improvement. However, some IRSSs and SSRIs are potent inhibitors of cytochrome P450 2D6 (CYP 2D6), which impacts on the concentration of endoxifen and should be avoided in patients treated with tamoxifen. In this case, citalopram and venlafaxine are a better therapeutic option, although there is some controversy regarding its consequences on recurrence and survival of breast cancer. The efficacy in the treatment of VMS with antidepressants is lower than that achieved with estrogens and there are few publications comparing both treatments. Neither is clear the optimal treatment duration. Two antiepileptic drugs have also shown to be effective, gabapentin and pregabalin. Some comparative studies are in progress and it is probably necessary to wait for their results to identify the optimal option in the management of menopausal symptoms in women who have had breast cancer.

Palabras clave : Breast cancer; Vasomotor symptoms; Antihypertensives; Antidepressants; Antiepileptics.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons